Financing led by Velan Capital with participation from new and existing healthcare-focused institutional investors and ...

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...

Nano-X Imaging is a disruptive biotech investment. The AI push in the health sector is a long-term tailwind. See why we rate ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Irhythm Technologies (IRTC – Research Report), Vir ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

It was a busy week for the biotech sector, as the fourth-quarter earnings season is in full swing. While Gilead Sciences, Inc ...

The aggregate gross proceeds to the Company from the offering were approximately $1,050,000, before deducting the placement ...